These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 20442307

  • 21. ELR510444, a novel microtubule disruptor with multiple mechanisms of action.
    Risinger AL, Westbrook CD, Encinas A, Mülbaier M, Schultes CM, Wawro S, Lewis JD, Janssen B, Giles FJ, Mooberry SL.
    J Pharmacol Exp Ther; 2011 Mar; 336(3):652-60. PubMed ID: 21148249
    [Abstract] [Full Text] [Related]

  • 22. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
    Wang S, Akhtar J, Wang Z.
    Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
    [Abstract] [Full Text] [Related]

  • 23. Cell fate after mitotic arrest in different tumor cells is determined by the balance between slippage and apoptotic threshold.
    Galán-Malo P, Vela L, Gonzalo O, Calvo-Sanjuán R, Gracia-Fleta L, Naval J, Marzo I.
    Toxicol Appl Pharmacol; 2012 Feb 01; 258(3):384-93. PubMed ID: 22178383
    [Abstract] [Full Text] [Related]

  • 24. Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.
    Whang YM, Park KH, Jung HY, Jo UH, Kim YH.
    Cancer; 2009 Mar 15; 115(6):1253-66. PubMed ID: 19156899
    [Abstract] [Full Text] [Related]

  • 25. An antitubulin agent BCFMT inhibits proliferation of cancer cells and induces cell death by inhibiting microtubule dynamics.
    Rai A, Surolia A, Panda D.
    PLoS One; 2012 Mar 15; 7(8):e44311. PubMed ID: 22952952
    [Abstract] [Full Text] [Related]

  • 26. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
    Honore S, Kamath K, Braguer D, Horwitz SB, Wilson L, Briand C, Jordan MA.
    Cancer Res; 2004 Jul 15; 64(14):4957-64. PubMed ID: 15256469
    [Abstract] [Full Text] [Related]

  • 27. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z, Gao M, Zhang H, Guan Q, Xu J, Li Y, Qi H, Li Z, Zuo D, Zhang W, Wu Y.
    Cancer Lett; 2017 Aug 28; 402():81-92. PubMed ID: 28576750
    [Abstract] [Full Text] [Related]

  • 28. Belinostat and vincristine demonstrate mutually synergistic cytotoxicity associated with mitotic arrest and inhibition of polyploidy in a preclinical model of aggressive diffuse large B cell lymphoma.
    Havas AP, Rodrigues KB, Bhakta A, Demirjian JA, Hahn S, Tran J, Scavello M, Tula-Sanchez AA, Zeng Y, Schmelz M, Smith CL.
    Cancer Biol Ther; 2016 Dec 28; 17(12):1240-1252. PubMed ID: 27791595
    [Abstract] [Full Text] [Related]

  • 29. DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells.
    Podolski-Renić A, Banković J, Dinić J, Ríos-Luci C, Fernandes MX, Ortega N, Kovačević-Grujičić N, Martín VS, Padrón JM, Pešić M.
    Eur J Pharm Sci; 2017 Jul 15; 105():159-168. PubMed ID: 28502672
    [Abstract] [Full Text] [Related]

  • 30. Delineating the interaction of combretastatin A-4 with αβ tubulin isotypes present in drug resistant human lung carcinoma using a molecular modeling approach.
    Kumbhar BV, Bhandare VV, Panda D, Kunwar A.
    J Biomol Struct Dyn; 2020 Feb 15; 38(2):426-438. PubMed ID: 30831055
    [Abstract] [Full Text] [Related]

  • 31. Natural product Celastrol destabilizes tubulin heterodimer and facilitates mitotic cell death triggered by microtubule-targeting anti-cancer drugs.
    Jo H, Loison F, Hattori H, Silberstein LE, Yu H, Luo HR.
    PLoS One; 2010 Apr 23; 5(4):e10318. PubMed ID: 20428237
    [Abstract] [Full Text] [Related]

  • 32. The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.
    Vetter NS, Kolb EA, Mills CC, Sampson VB.
    Mol Cancer Res; 2017 Jul 23; 15(7):953-964. PubMed ID: 28275089
    [Abstract] [Full Text] [Related]

  • 33. Cancer cells acquire mitotic drug resistance properties through beta I-tubulin mutations and alterations in the expression of beta-tubulin isotypes.
    Cheung CH, Wu SY, Lee TR, Chang CY, Wu JS, Hsieh HP, Chang JY.
    PLoS One; 2010 Sep 03; 5(9):e12564. PubMed ID: 20838440
    [Abstract] [Full Text] [Related]

  • 34. Slug increases sensitivity to tubulin-binding agents via the downregulation of βIII and βIVa-tubulin in lung cancer cells.
    Tamura D, Arao T, Nagai T, Kaneda H, Aomatsu K, Fujita Y, Matsumoto K, De Velasco MA, Kato H, Hayashi H, Yoshida S, Kimura H, Maniwa Y, Nishio W, Sakai Y, Ohbayashi C, Kotani Y, Nishimura Y, Nishio K.
    Cancer Med; 2013 Apr 03; 2(2):144-54. PubMed ID: 23634282
    [Abstract] [Full Text] [Related]

  • 35. NMK-TD-100, a novel microtubule modulating agent, blocks mitosis and induces apoptosis in HeLa cells by binding to tubulin.
    Bhattacharya S, Kumar NM, Ganguli A, Tantak MP, Kumar D, Chakrabarti G.
    PLoS One; 2013 Apr 03; 8(10):e76286. PubMed ID: 24116100
    [Abstract] [Full Text] [Related]

  • 36. Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest.
    Mohan R, Panda D.
    Cancer Res; 2008 Aug 01; 68(15):6181-9. PubMed ID: 18676841
    [Abstract] [Full Text] [Related]

  • 37. The tubulin-depolymerising agent combretastatin-4 induces ectopic aster assembly and mitotic catastrophe in lung cancer cells H460.
    Cenciarelli C, Tanzarella C, Vitale I, Pisano C, Crateri P, Meschini S, Arancia G, Antoccia A.
    Apoptosis; 2008 May 01; 13(5):659-69. PubMed ID: 18386182
    [Abstract] [Full Text] [Related]

  • 38. A synthetic podophyllotoxin derivative exerts anti-cancer effects by inducing mitotic arrest and pro-apoptotic ER stress in lung cancer preclinical models.
    Chen JY, Tang YA, Li WS, Chiou YC, Shieh JM, Wang YC.
    PLoS One; 2013 May 01; 8(4):e62082. PubMed ID: 23646116
    [Abstract] [Full Text] [Related]

  • 39. The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1.
    Chang LC, Yu YL, Liu CY, Cheng YY, Chou RH, Hsieh MT, Lin HY, Hung HY, Huang LJ, Wu YC, Kuo SC.
    Cancer Chemother Pharmacol; 2015 Jun 01; 75(6):1303-15. PubMed ID: 25947085
    [Abstract] [Full Text] [Related]

  • 40. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
    Dinić J, Ríos-Luci C, Karpaviciene I, Cikotiene I, Fernandes MX, Pešić M, Padrón JM.
    Invest New Drugs; 2020 Jun 01; 38(3):584-598. PubMed ID: 31177401
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.